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Abstract
Background: Assessment of risk and early diagnosis of Alzheimer’s disease (AD) is a key to its prevention or
slowing the progression of the disease. Previous research on risk factors for AD typically utilizes statistical
comparison tests or stepwise selection with regression models. Outcomes of these methods tend to emphasize
single risk factors rather than a combination of risk factors. However, a combination of factors, rather than any one
alone, is likely to affect disease development. Genetic algorithms (GA) can be useful and efficient for searching a
combination of variables for the best achievement (eg. accuracy of diagnosis), especially when the search space is
large, complex or poorly understood, as in the case in prediction of AD development.
Results: Multiple sets of neuropsychological tests were identified by GA to best predict conversions between
clinical categories, with a cross validated AUC (area under the ROC curve) of 0.90 for prediction of HC conversion
to MCI/AD and 0.86 for MCI conversion to AD within 36 months.
Conclusions: This study showed the potential of GA application in the neural science area. It demonstrated that
the combination of a small set of variables is superior in performance than the use of all the single significant
variables in the model for prediction of progression of disease. Variables more frequently selected by GA might be
more important as part of the algorithm for prediction of disease development.
Introduction
There is agreement that the identification of risk factors
for AD is important for both the diagnosis and prog-
nosis of the disease AD [1]. Diagnosis of AD can not be
made by a single test and requires careful medical eva-
luation, including medical history, mental status testing,
physical and neurological exam, blood test and braining
imaging etc. To this end there now exist large prospec-
tive studies of healthy older adults at risk for AD due to
their age. Studies such as the Australian Imaging Bio-
markers and Lifestyle (AIBL) Study of Ageing [2,3], the
Alzheimer’s disease Neuroimaging Initiative (ADNI)
study [4,5] or the Mayo Clinic Study of Aging [6,7]
measure a multitude of putative cognitive, biological, neu-
roimaging and lifestyle measures repeatedly. They aim to
identify measures, or combination of measures that pro-
vide the earliest and most accurate prediction of progres-
sion to clinically classified AD. While the results of these
studies suggest that body fluid and neuroimaging biomar-
kers of amyloid have great promise for early detection of
AD, neuropsychological assessments of cognitive function
have provided measures that are excellent predictors of
progression to dementia [8].
Prospective studies like AIBL and ADNI, typically apply
multiple neuropsychological tests, each hypothesized to
measure different aspects of cognitive function, to their
patient groups in repeated assessments. The objective of
this approach is to identify performance measures upon
which impairment or its change over time indicate the
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presence of early AD [9-11]. However, the use of multiple
neuropsychological tests, each of which can also yield
multiple outcome measures, provides a substantial analy-
tic challenge in identifying which of these measures,
either by themselves or in combination with others, are
most predictive of dementia.
Many studies have considered each measure from
each neuropsychological test as independent and con-
ducted multiple analyses investigating the predictive
value of each, e.g. [12-14]. Other studies have sought to
limit analyses by restricting the number of outcome
measures per neuropsychological test [12]. Both of these
approaches are problematic because the multiple ana-
lyses increase the potential for the identification of false
positive relationships. Other approaches have sought to
understand the extent to which the different measures
from different tests are actually related to one another
by combining different outcome measures into theoreti-
cally based composite scores or by deriving sets of
weighted composite scores from factor analysis [12,9].
These approaches to combining data do reduce the
number of variables used in statistical analyses and
thereby reduce the potential for identification of false
positive relationships. However, the use of theoretically
derived composite scores might also reduce the accuracy
of prediction through inclusion of non-informative mea-
sures into these composite scores. Furthermore, while
factor analytic solutions may improve definition of latent
cognitive traits in a data set, the identified factors often
have very little theoretical utility in the context of AD
models [12]. Therefore, there is a need for exploration
of other methods for combining data from neuropsycho-
logical tests batteries.
Genetic algorithms (GA) are machine learning search
techniques inspired by Darwinian evolutionary models.
The advantage of GA over factor analytic and other such
statistical models is that GA models can address problems
for which there is no human expertise or where the pro-
blem seeking a solution is too complicated for expertise
based approaches. GA can be applied to challenges which
can be formulated as function optimization problems.
This makes GA ideal for application to discrete combina-
torial problems and mixed-integer problems [15]. Thus
the GA approach is appropriate for finding solutions that
require efficient searching of a subset of features to find
combinations that are near optimal for solving high-
dimensional classification problems, especially when the
search space is large, complex or poorly understood. The
identification of the measures from multiple neuropsycho-
logical tests optimal for classifying early AD can be con-
strued as such a problem. Thus with GA, the outcome
measures of neuropsychological tests can be considered as
features and a classification goal that the optimal combina-
tion of the tests is to achieve can be represented by a
fitness (objective) function. Therefore the GA may be use-
ful in identifying which neuropsychological measure or
combination of measures from the baseline assessment in
the AIBL study. They are helpful in identification of indivi-
duals whose disease has progressed to meet clinical criteria
for mild cognitive impairment or Alzheimer’s disease 36
months later. The aim of this study was therefore to use
GA to determine and quantify the predictive value of com-
binations of neuropsychological measures for prediction of
progression to MCI or AD from a normal healthy classifi-
cation, and for prediction of progression to AD from MCI.
Methodology
The goal of this study was to find the combinations of fea-
tures that produce best-performing predictive models of
AD early diagnosis and progression. In this study, a GA
was used to select one or more sets of neuropsychological
tests (features) which can predict AD progression with
high accuracy and a logistic regression (LR) algorithm was
used to build prediction models. The architecture of the
algorithm and the system that combined GA and LR for
the prediction of the AD status are shown in Figure 1. The
features selected by the GA search were used as the input
for LR, and the results from LR with different variable sets
were used by the GA to perform an optimization and
identify the best feature set. A similar method was used
earlier in the study of heart disease [16,17].
Data
A battery of neuropsychological and mood rating scales is
given as part of the AIBL study. For this study data from
the baseline assessment was used to predict the clinical
classification of individuals at the 36 month assessment.
The full assessment battery of tests comprised the:
• Mini-Mental State Examination (MMSE) [18]
• Logical Memory I and II (LM) - (WMS; Story 1 only)
[19],
• California Verbal Learning Test - Second Edition
(CVLT-II) [20],
• the Rey Complex Figure Test (RCFT) [21],
• D-KEFS verbal fluency (D-KEFS) [20],
• 30-item Boston Naming Test (BNT) [22],
• Digit Span and Digit Symbol-Coding subtests of the
Wechsler Adult Intelligence Scale - Third Edition
(WAIS-III) [23],
• the Stroop task (Victoria version) [24],
• Clock Drawing Test (CDT)[25],
• Wechsler Test of Adult Reading (WTAR) [26],
• Clinical Dementia Rating scale (CDR) [27], and
• Hospital Anxiety and Depression Scale (HADS) [28].
A comprehensive account of the cognitive battery of
tests and the rationale behind the selection of individual
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tests was described in our previous paper [29]. The set
of 37 cognitive and mood tests that covered the tests
listed above and were used in our algorithm for selec-
tion of best feature subsets for prediction of AD pro-
gression are shown in Table 1. The Z scores of the
tests, normed and age adjusted [29], were used in this
study when available, otherwise raw scores were used.
The AIBL population consisted of individuals aged 60
years or more who were classified as cognitively healthy,
or who met clinical criteria for either the mild cognitive
impairment (MCI) or AD. The diagnostic criteria and
methods were previously described in [29]. After exclud-
ing the ones unavailable in 36 months(148), 13 deceased
and 1 converted to vascular dementia from the total 797
HC cohort, the data set used for this research included
31 healthy controls (HC) who converted to either mild
cognitive impairment (MCI) or to AD, and 604 who
remained healthy over 36 months. These baseline data
were used for building the models for prediction of HC
conversion. The baseline MCI cases (47 converters and
30 non-converters at 36 months) were used to build the
MCI conversion models, after excluding 49 unavailable
Figure 1 The architecture of the system that combined the GA and LR in our study. The search process involved three principal steps. LR
was used with each set of features to make a predictive model for each instance within the possible solutions in GA. The subsequent cycles of the GA
search find better solutions that replace less fit solutions found previously. This process is iteratively repeated until the goal solutions are found.
Table 1 A complete set of neuropsychological tests used in this study.
Source Cognitive test - feature # Source Cognitive test - feature #
MMSE Mini Mental State Exam * 1 BNT No Cue Australian 20
LM Logical Memory I * 2 No Cue US 21
Logical Memory II * 3 WAIS-III Digit span 22
Logical Memory Pass /Fail * 4 Digit symbol-Coding 23
CVLT-II Total Learning (List A Trials 1-5) 5 UK Pred Full Score IQ * 24
List A T6 Retention 6 US Pred Full Score IQ * 25
List A 30 min Delayed Recall 7 Stroop Dots time 26
List A Recognition 8 Dots errs * 27
List A False Positives 9 Words time 28
Total Recognition d’ 10 Words errs * 29
RCFT Rey Complex Figure Copy 11 Colours time 30
Rey Complex Figure Copy time 12 Colours errs * 31
Rey Complex Figure 3 min delay 13 C/D 32
Rey Complex Figure 30 min delay 14 CDT Clock score * 33
Rey Complex Figure Recog 15 WTAR WTAR IQ score * 34
D-KEFS Letter Fluency 16 CDRSoB CDR Sum of Boxes * 35
Category Fluency 17 HADS Depression 36
Category Switching Total 18 Anxiety 37
Category Switching (switches) 19
Each test is given a number (column #) that would be referred in the rest of the paper. * Z scores were not available or not applicable.
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ones in 36 months, 13 deceased and 3 converted to
other dementias.
Genetic algorithm
In GA, the potential solutions compete and mate with
each other to produce increasingly fitter individuals over
multiple generations. Each individual in the population
(called genome or chromosome) represents a candidate
solution to the problem. In our study genomes were
represented by binary strings each encoding a set of fea-
tures (variables) representing cognitive tests.
A flow chart describing the overall GA used in this
study is shown in Figure 2. Each individual in the popu-
lation represents a candidate solution for feature subset
selection problem from the set of 37 cognitive tests. The
search space comprises 237 possible feature subsets.
Each variable (cognitive test) in the GA was represented
as a bit in the individual genome. A binary vector of
length 37 represents each individual in the population
of possible solutions. Each genome contained 37 bits,
one bit for each feature/cognitive test. A bit value of
zero (0) indicated that the corresponding feature was
not selected, and a value one (1) indicated that the
feature was selected. The initial population of potential
solutions was randomly generated. Two-point crossover
was chosen for reproduction of the next generation,
noted as an optimal form of crossover for binary GAs in
[30]. This involves selecting two random points within a
genome of one parent and swapping the section
between these exact two points with a second parent.
For each crossover, two new individuals for the next
generation were created, shown in Figure 3.
The type of mutation chosen for the GA algorithm
implementation was a single bit flip mutation, This was
chosen to prevent large changes to the binary genome.
Large changes are more likely to result in instability and
most often result in a less fit solution after the mutation
operation. The mutation operation was performed by
randomly selecting a single bit on the genome and flip-
ping it. An example of single point mutation is shown
in Figure 4.
The selection of individuals for mating was done using
the tournament selection. This method helps minimise
early convergence of the algorithm. Early convergence
of GA often produces poor solutions. The tournament
selection allows for easily adjustment of selection
Figure 2 Diagram representing the GA search. Each solution within a generation is evaluated until the target solution is found. New
generation of the population is produced using selection, crossover, and mutation operators that create new solutions. The “best” solution is
returned when fitness function reaches target value
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pressure by selection of tournament size to further help
tune the algorithm [31]. The tournament selection was
performed by first taking a random sample from the
population of the given tournament size. This individual
“tour” was then used to select one parent by selecting
the genome with the highest fitness. This sampling was
then performed for the second parent, where the first
parent could not be reselected. Crossover or mutation
was then performed to these 2 parent individuals, with
the chosen crossover and mutation rates. The two gen-
omes produced by this process were then placed into
the next generation. Elitism was used in the GA to
ensure the best result was not lost from generation to
generation. The fittest individual from the previous gen-
eration was copied and placed into the next generation
replacing the least fit individual.
The best solutions, those that represent the fittest
individuals, were defined as the sets of features that best
classify the conversions from HC to MCI/AD or the
conversions from MCI to AD, within 36 months, as
assessed by the fitness function. To evaluate the fitness
of any of the solutions, LR was used to build a predic-
tion model using the given subset of features. The fit-
ness of the genome was estimated by calculating the
area under the curve of a receiver operating characteris-
tic (ROC) produced by the LR model. Repeated five-fold
balanced and stratified cross-validation [32] was used to
assess the performance of the LR models.
The ROC curve is a graphical representation of the
trade-off for every possible cut off (or a close approxima-
tion) between sensitivity (SE) and specificity (SP) [33]. It
is calculated as an area under the ROC curve (AUC) that
connects points (1-SP, SE) on the (x,y) plot for a range of
values of SP that include SP = 0, SP = 1, and a number of
values in between these two values. The plot provides a
unified measure of the ability of a test to make correct
classification being examined over all decision thresholds.
The values of AUC = 0.5 indicate random guessing, AUC
= 1 indicates perfect prediction, AUC = 0 is also perfect
prediction but with class label switched. Furthermore the
practical implications for majority of classification
systems are that values of AUC>0.9 indicate excellent
predictions, AUC>0.8 are good predictions, while
AUC<0.7 indicate poor predictions [34].
Logistic regression and fitness function
The main purpose of a fitness function is to evaluate the
quality of each proposed solution. The function that
evaluated the performance of models generated from
any given variable set was based on the output result
from the logistic regression model:
E
(
y
)
=
et
1 + et
(1)
where y = 1, in this study, if the case converted from
HC to MCI/AD or from MCI to AD in 36 months; y =
0, if the case didn’t convert.
E(y) is the probability for conversion, that is for y = 1,
in this study.
t is a linear function of explanatory variables that can
be written as:
t = β0 + β1x1 + β2x2 + . . . + βkxk (2)
where x1, x2 . . . xk are the independent features (vari-
ables), and for this study they are the variables representing
the cognitive test scores included in Table 1.
The AUC was used as the fitness function in the
GA. This fitness function generally works well, but
when in feature selection problems it tends to select
larger feature sets. In this study, we aimed to select
smaller variable sets that give similar classification
results as the larger variable sets. Smaller variable sets
have better utility because they are easier to under-
stand and interpret. The collection of small sets of
features is easier, faster and less costly, so it can be
done more frequently. In clinical settings the collec-
tion of smaller variable sets has practical advantages
since data collection is faster, cheaper, and easier for
both patients and medical staff. To facilitate identifi-
cation of small feature sets that are highly predictive,
a penalty element was assigned to the larger variable
Figure 3 An example of a 2-point crossover . Two parent
solutions exchange segments of their genomes. The swapped
segments are from position 1 to Point 1, and from point 2 to
position 37 of the genomes. Subsequently, the fitness of each
solution is assessed, and if the fitness is improved the new “best”
solution is added to the population of solutions.
Figure 4 Schematic showing a single point mutation. In this
example, position 35 was mutated from 1 to 0. The meaning of this
transformation is that the corresponding feature (HADS Anxiety) was
selected before the mutation and unselected after mutation.
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sets in the fitness function:
fitness(genome) = AUC + ρ − ρl
n
(3)
where ɭ is the number of active variable’s for the
given genome, AUC is the area under the ROC curve, n
is the total number of features and r is the compromise
factor. More specifically, r is the offset of the ROC fit-
ness that can be traded off to allow for selection of a
smaller variable set.
Implementation and cross-validation
The GA process was implemented in C programming
language. The logistic regression models were built from
the GLM function included in R [35] within the GA
process, for each genome, the LR result was validated
using repeated five-fold balanced and stratified cross-
validation. Stratification was carried out by splitting the
data into two sets, signifying positive and negative out-
comes (e.g., cases converted to MCI from HC and the
ones not converted). Each set was further divided at
random into five equal folds, where fold size equality
was enforced by the random removal of maximum one
data point per fold. For each of the folds in turn, one
part was used as validation data with the remaining
parts used as training data to obtain an AUC value. The
five AUC values from each of the validation data sets
across the folds were averaged to obtain a single overall
AUC value. The process of five-fold balanced and strati-
fied cross-validation is repeated five times with different
fold data combinations to mitigate the effects of bias in
small observation datasets. The AUC value in the fitness
function (3) is the average value of the five AUC values
from the repeated cross-validation.
Each final LR model with the variable set selected
from the GA was further analysed using Monte Carlo
(MC) cross-validation. The data was randomly split into
80% for LR model training and 20% for validation. This
was repeated for 1,000 runs and the AUC was averaged
to give the final number. The repeated cross-validation
technique employed by the fitness function was success-
ful in minimising the bias encountered by non-repeated
or fixed fold techniques. The higher accuracy of greater
repetition averaging was not allowed due to high com-
putational cost across the whole population over many
generations. However, at the completion of the GA run,
MC cross-validation on the final genome is less costly.
This final cross-validation gave an AUC value that was
used to compare the variable sets selected by each of
the GA runs.
In this study, the GA was run multiple times for find-
ing the best feature sets that predict conversion from
HC to MCI/AD and conversion from MCI to AD
respectively. A frequency chart was created from the
features selected by all the GA runs to identify singular
features that were selected more frequently than others.
Simulations
In GA terminology, the specific runs are also called
“experiments”. This application has been developed for
clinical settings, where an experiment often means wet-lab
work or a clinical procedure. To prevent confusion, we
call in silico experiments (GA runs) “simulations”. GAs are
by their nature very robust, however finding an optimal
solution is not guaranteed when GA is used. To make the
convergence of GA towards an optimal solution, we tried
different search parameters.
The final values of search parameters were:
Population: 50
Mutation rate: 10%
Crossover rate: 90%
Tournament size: 2
Number of generation: 300
The final r value 0.085 in the fitness function was
chosen to find relatively small sized variable sets that
produce well-performing models for prediction of AD
progression. The GA was run 50 times to find multiple
sets of features that best (or close to best) predict the
conversions from HC to MCI/AD or conversion from
MCI to AD. The comparison of multiple runs allowed
us to summarize frequencies of the features that appear
in the best solutions selected by the GA search.
Comparison with stepwise variable selection
To determine how well the GA performance compar-
ing to more traditional statistical optimization techni-
ques, a stepwise (SW) algorithm was deployed and the
results were compared to those produced by the GA.
The stepwise method started from a model that con-
tained all the factors and a single factor was removed
at each step until such point when removing any more
factors would make the model worse. The actual step-
wise function used was the stepAIC function from the
MASS package [36]. The results were compared using
paired t-tests.
Building the final prediction models from the selected
variable sets
To determine how the sets of features (variables) selected
by the GA contribute to the classification models, logistic
regression models were built using the complete set of
available data with the GLM (General Linear Model)
function from R. The models from representative variable
sets from simulations define the t function in equation
(2) for the HC to MCI/AD and MCI to AD conversion
models, respectively.
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Results
Prediction of conversion from HC to MCI or AD at 36 months
Each run of the GA might find different ‘best’ set of fea-
tures. Even for the same set of variables that were
found, the AUC might be slightly different due to the
differences in cross-validation sets associated with the
individual runs. Initial inspection of feature combina-
tions selected by the GA showed that the partitions pro-
duced equivalent prediction result (ROC). Some of the
features were more consistently selected by the GA
across different runs. Table 2 shows the results from
multiple GA runs that predicted conversion of HC to
MCI or HC to AD. The “Run #” is the GA run number
(renumbered after 50 runs, ordered by the number of
features in the feature sets from smallest to largest). The
“MC_AUC” is the AUC value produced from the LR
model using the GA selected variable set, validated by
MC cross validation. The “Number of Variables” shows
how many features were included in the feature set,
with the corresponding features showed in the Column
“Variables”. Each feature is represented by a number
matched to the cognitive test shown in Table 1. The
series of numbers shown as “Variables” in Table 2 indi-
cate the tests selected as the feature set. Variables 3, 5
and 18 (Logical Memory II, CVLT-II Total Learning
and D-KEFS Category Switching Total) were frequently
observed (>80%) in the final sets selected by the GA
search (Figure 5). Together, these three features provide
classification accuracy of AUC = 0.89. Furthermore,
these three features are present in all selections that
produced better results (AUC = 0.90 or AUC = 0.91)
indicating they are critical for this task. Runs 7 and 8
have all five features that are present at frequency >40%,
but their predictive performances are equal to perfor-
mance of the three key features. Features 1 and 35
(Mini-Mental State Exam and CDR Sum of Boxes) are
also frequently selected (>40%), however they appear to
be redundant variables. To check whether there are any
redundancies in the small size variable set (3,5,18) that
performed well, we also checked the combinations of
Table 2 GA results, HC to MCI or AD Conversion over 36 months.
Run# MC_AUC Number of
Variables
Variables
(see Table 1)
Run # MC_AUC Number of
Variables
Variables
(see Table 1)
1 0.89 3 3;5;18 26 0.89 7 3;5;6;15;18;21;35
2 0.90 4 1;3;5;18 27 0.88 7 3;5;6;13;15;18;35
3 0.88 4 3;5;6;30 28 0.89 7 3;5;7;18;20;33;35
4 0.86 4 3;6;16;33 29 0.88 7 3;5;6;16;18;20;35
5 0.89 5 1;3;5;6;18 30 0.89 7 3;5;7;15;18;33;35
6 0.90 5 1;3;5;18;29 31 0.89 7 3;5;7;18;20;35
7 0.89 5 1;3;5;18;35 32 0.87 7 3;5;6;13;15;35;37
8 0.89 5 1;3;5;18;35 33 0.88 7 3;5;7;15;18;21;35
9 0.89 5 1;3;5;18;28 34 0.89 7 2;3;5;7;8;18;35
10 0.89 5 3;5;18;22;35 35 0.90 7 3;5;6;16;17;18;35
11 0.89 5 3;5;15;18;35 36 0.88 7 1;3;5;7;18;33;28
12 0.89 5 3;5;6;18;33 37 0.88 7 1;3;5;7;12;19;33
13 0.87 5 1;3;6;18;33 38 0.89 7 2;3;5;9;15;18;35
14 0.88 5 1;3;6;18;20 39 0.89 8 1;2;3;5;6;15;18;35
15 0.88 5 2;3;5;30;35 40 0.88 8 1;3;5;7;15;18;20;35
16 0.87 5 1;3;6;9;16 41 0.89 8 2;3;5;7;18;20;33;35
17 0.89 6 3;5;6;18;20;35 42 0.90 8 1;3;5;12;13;14;17;18
18 0.89 6 3;5;6;18;21;35 43 0.88 8 1;2;3;5;7;15;18;35
19 0.89 6 1;3;5;7;8;18 44 0.89 8 1;3;5;7;8;18;20;33
20 0.89 6 3;5;6;15;18;35 45 0.89 8 1;3;5;13;14;18;33;35
21 0.89 6 3;5;6;18;35 46 0.88 8 3;7;12;18;24;30;35;36
22 0.89 6 3;5;6;18;33;28 47 0.91 9 1;3;5;7;8;13;16;17;18
23 0.88 6 2;3;5;6;15;28 48 0.89 9 2;3;5;7;8;16;18;20;35
24 0.88 6 3;5;7;15;19;23 49 0.90 9 1;3;5;7;8;13;18;33;29
25 0.90 7 1;3;5;16;17;18;35 50 0.90 11 1;3;5;6;8;12;16;17;18;20;35
The MC_AUC stands for AUC produced by the LR models for given sets of selected features. Variable sets with variable numbers ranging from 3 to 11 were
found by the GA.
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any 2 of the 3 variables, the prediction results from
these 2-variable sets are all lower than using all 3 of the
variables (Table 3). We checked the prediction perfor-
mance from the models with each individual variable
alone as an independent variable, there was not a single
one variable that could perform better than the combi-
nation of variables 3, 5 and 18.
Our results indicated that, for prediction of conversion
from HC to MCI/AD the solution is dominated by the
three features - 3, 5 and 18 that stand for Logical Memory
II, CVLT-II Total Learning and D-KEFS Category Switch-
ing Total respectively. It appears that there is a redun-
dancy in some tests. The inspection of results indicates
that classification properties captured by feature 5 are
most likely also captured by other variables, for example,
1, 20, and 33; properties captured by variable 18 are most
likely captured by variables 6, 7, 15, and 35 etc; while fea-
ture 3 is essential. To make sure the solutions found by
the GA are better than random chance selections, 100 sets
of random variables for each corresponding length of fea-
ture set were selected and compared with the result from
the GA selections. The results showed that the GA found
better models than random chance (p < 10-15, t-test), see
Table 4.
Prediction of conversion from MCI to AD
Variables that occur frequently (>60%) in the feature sets
include variables 10, 15, 19, 31 and 35 that stand for
CVLT-II Total Recognition d’, Rey Complex Figure Recog-
nition, D-KEFS Category Switching (switches), Stroop Col-
ours errs, and CDR Sum of Boxes, respectively. A number
of other features occur with medium (>20%) frequency.
The results from the 50 GA runs for predicting the con-
version from MCI to AD are shown in Table 5. The fre-
quencies of the variables being selected by GA in the final
sets are shown in Figure 6. Notably the sets of features
that make best predictors of conversion of MCI to AD do
not overlap feature sets that are best predictors of conver-
sion from HC to MCI/AD (only variables 1 and 35 appear
frequently in both). The predictive performance of most
MCI to AD conversion feature sets were AUC>0.85, with
best predictive performance observed in predictors that
use 4-8 features. The model with the 5 most frequently
selected variables 10, 15, 19, 31, and 35 was also tested
(run #12), providing an AUC value of 0.85. Run #14 with
variables 10, 19, 24, 31, and 35 provided a similar AUC of
0.86, demonstrating that many combinations perform well
(irrespective of individual variable selection frequency) and
highlighting the power of the GA approach. Furthermore,
the comparison with randomly selected feature sets
showed superior performance of GA-selected features (p <
10-15, t-test), Table 6, indicating superior performance of
the GA in this feature selection task.
Comparison with stepwise variable selection
The comparative results from GA and the Stepwise
Optimization with the constraint for sample size are
shown in Table 7. For prediction of conversion from
HC to MCI/AD, the performance of variable sets
selected by GA and those selected by stepwise algo-
rithm did not show significant difference. The result
indicated that features 18 (Category Switching Total)
and 19 (Category Switching (switches)) are very simi-
lar but feature 18 is preferred in most predictors. The
Figure 5 Frequencies of the variables selected by GA, for prediction of conversion from HC to MCI or AD in 36 months. Four features
with frequencies greater than 50% (3, 5, 18 and 35; see Table 1 for details) were selected by the GA (in 50 runs).
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feature sets selected by GA for prediction of conver-
sion from MCI to AD were significantly better predic-
tors than the features selected by stepwise algorithm
(p = 0.002).
Final LR prediction models built from selected variable
sets
To check the contribution of each variable in the mod-
els, we built the models with the whole set of data using
the selected variable sets from GA and stepwise selec-
tions. Models m1G, m2G, m3G and m4G (below) were
built using the variables selected by GA, and m1S, m2S,
m3S and m4S are the models built using the variables
selected by the stepwise algorithm. tHCcon and tMCIcon
represent the t functions in equation (2) for HC to
MCI/AD and MCI to AD conversion. The vi are the
explaining variables in the equation, representing vari-
ables from Table 1, for example, v1 represents variable 1
in Table 1 (Mini-Mental State Exam). The p values for
each variable in the models were from the z statistical
tests against the null hypothesis that the true value of
each coefficient is 0, and they are shown in Table 8.
tHCcon = 13.43− 0.31v1 − 0.27v3 − 0.06v5 − 0.18v18 (m1G)
tHCcon = 6.001− 0.28v3 − 0.078v5 + 0.74v8 − 0.19v18 (m1S)
tHCcon = 17.58− 0.46v1 − 0.293v3 − 0.07v5 − 0.31v7
+0.84v8 − 0.29v13 − 0.11v16 + 0.25v17 − 0.23v18 (m2G)
tHCcon = −3.98 − 0.27v3 − 0.07v5 + 0.82v8 + 0.53v9
−0.13v16 + 0.20v17 − 0.21v18 − 0.008v25 + 1.01v33 (m2S)
tMCIcon = −10.84− 1.64v10 − 0.32v19 + 0.10v24 + 0.56v31 + 0.89v35(m3G)
tMCIcon = −1.84− 1.28v10 + 0.21v16 − 0.31v19 − 1.23v27 + 1.49v35 (m3S)
tMCIcon = −14.40− 0.32v1 − 1.48v10 − 0.60v15 − 0.35v19
−0.12v24 + 0.49v31 − 0.30v32 + 0.77v35 (m4G)
tMCIcon = −11.16− 2.02v10 + 0.22v16 + 0.37v18 − 0.73v19
+0.08v24 − 1.24v27 + 0.48v28 + 1.22v35 (m4S)
When assessed individually, some of the variables did
not show significant difference between converters and
non-converters. They, however, contributed to the model
performance significantly as covariates (see Table 7 and 8).
Our results show that the average value of some variables,
such as v8 (List A Recog), v15 (RCFT Recog), v16 (Letter
fluency) and v33 (Clock score), for HC, MCI and AD
groups were HC>MCI>AD, as expected (Table 9). The
group who converted from HC to MCI/AD or MCI to AD
within 36 months had higher values than the non-conver-
ters but these differences were not statistically significant.
These variables might be important for clinical diagnosis
of AD patients, but any single feature alone is not predic-
tive of the disease progression. However, when combined
with other tests, individual feature can contribute to the
multivariate models significantly and the feature sets are
potentially useful as prognostic tests.
Conclusion and discussion
The GA was good at finding high accuracy solutions but
the reported models are not necessarily the absolute best
Table 3 AUC values from the LR models with each single variable or with any 2 of the most selected 3 features
(variables).
Variable# 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
AUC 0.69 0.71 0.80 0.59 0.77 0.78 0.78 0.54 0.75 0.70 0.61 0.58 0.59 0.58 0.57 0.54 0.54 0.71 0.71
Variable# 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37
AUC 0.52 0.51 0.53 0.61 0.51 0.57 0.55 0.50 0.61 0.51 0.64 0.51 0.59 0.53 0.55 0.59 0.60 0.53
Variable set
(with 2 variables)
5, 18 3, 5 3, 18
AUC 0.80 0.85 0.82
The best value for a single variable was AUC = 0.8, the best value for two variables was AUC = 0.85, while the best value for selected set of small number of
features was AUC = 0.90 (see Table 2).
Table 4 Variable selection from GA for prediction of
conversion from HC to MCI/AD, compared with random
selections of features.
# of
features
Average AUC
(GA selected variable
sets)
Average AUC
(randomly selected variable
sets)
3 0.89 0.69
4 0.88 0.71
5 0.89 0.74
6 0.89 0.75
7 0.89 0.77
8 0.89 0.77
9 0.90 0.77
11 0.90 0.79
The best performance is associated with sets comprising 3 to 11 features and
can be classified as good-to excellent performance (AUC≈0.9). Random
selection of features resulted in poor to borderline predictions (AUC<0.79).
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Table 5 GA results, MCI to AD Conversion over 36 months.
Run
#
MC_AUC Number of
Variables
Variables Run
#
MC_AUC Number of
Variables
Variables
(see Table 1)
1 0.86 4 10;19;24;31 26 0.85 6 10;15;19;31;34;35
2 0.82 5 1;8;10;19;24 27 0.86 6 1;10;15;19;34;31
3 0.83 5 10;18;23;25;31 28 0.86 6 1;10;15;19;25;31
4 0.83 5 1;10;14;19;23 29 0.86 6 9;15;19;24;31;35
5 0.83 5 5;9;24;23;35 30 0.86 6 9;10;15;18;23;31
6 0.84 5 10;19;21;25;31 31 0.86 6 10;15;19;24;31;35
7 0.84 5 10;16;19;20;35 32 0.87 6 1;10;15;19;24;31
8 0.85 5 10;16;19;23;35 33 0.84 7 8;10;18;25;31;33;34
9 0.85 5 10;15;16;18;31 34 0.85 7 10;16;19;23;25;31;34
10 0.85 5 10;19;20;25;31 35 0.85 7 1;10;15;19;24;31;33
11 0.85 5 9;23;25;31;35 36 0.85 7 1;8;10;15;19;25;31
12 0.85 5 10;15;19;31;35 37 0.86 7 9;10;15;18;24;31;35
13 0.86 5 10;19;24;31;35 38 0.86 7 1;10;15;19;31;34;35
14 0.86 5 10;19;24;31;35 39 0.86 7 1;8;10;15;18;25;31
15 0.83 6 5;10;15;19;31;35 40 0.86 7 1;10;15;19;31;34;35
16 0.84 6 1;3;10;19;25;31 41 0.86 7 1;10;15;19;24;31;35
17 0.84 6 1;10;19;24;30;31 42 0.87 7 1;10;15;19;31;34;35
18 0.84 6 1;15;19;20;34;35 43 0.87 7 1;10;15;19;25;31;35
19 0.84 6 10;19;23;24;31;35 44 0.87 7 1;10;15;19;25;31;35
20 0.84 6 3;10;19;23;31;35 45 0.87 7 1;10;15;19;25;31;35
21 0.85 6 1;10;19;23;31;35 46 0.87 7 10;15;16;18;20;31;35
22 0.85 6 10;16;19;24;31;35 47 0.87 7 1;10;15;19;24;31;35
23 0.85 6 9;15;18;23;31;35 48 0.85 8 3;10;15;16;19;21;25;35
24 0.85 6 8;10;15;18;25;31 49 0.86 8 1;10;15;19;24;31;35;36
25 0.85 6 1;10;15;19;23;31 50 0.87 8 1;10;15;19;24;31;32;35
The MC_AUC is the accuracy of predictions measured by the AUC value. The best results involve feature sets with 4-8 variables, while longer solutions (more
variables in the models) were rejected by the GA selection criteria (worse performance).
Figure 6 Frequencies of variables selected by GA, for prediction of conversion from MCI to AD in 36 months. Nine featuress were
present in frequencies larger than 20%. The pattern of frequencies is dominated by five features, each present in more than 60% of feature sets.
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Table 6 Variable selection from GA for prediction of conversion from MCI to AD, compared with random selections of
features.
# of features Average AUC
(GA selected variable sets)
Average AUC
(randomly selected variable sets)
4 0.86 0.67
5 0.85 0.67
6 0.85 0.68
7 0.86 0.69
8 0.86 0.69
The best performance is associated with the feature sets of lengths 7 and 8, that can be classified as good performance (0.9>AUC>0.8). Random selection of
features resulted in poor prediction (AUC<0.7).
Table 7 Results from the models selected by GA and from the stepwise algorithm.
Case Size GA Stepwise P_value
(t test)
Variables AUC Variables AUC
HC
to
MCI
3 3;5;18 0.89 3;5;19 0.88 0.366
4 1;3;5;18 0.90 3;5;8;18 0.89
5 1;3;5;18;29 0.90 3;5;8;17;18 0.89
6 1;3;5;7;8;18 0.89 3;5;8;16;17;18 0.90
7 3;5;6;16;17;18;35 0.90 3;5;8;9;16;17;18 0.90
8 1;3;5;12;13;14;17;18;35 0.90 3;5;8;9;16;17;18;33 0.91
9 1;3;5;7;8;13;16;17;18 0.91 3;5;8;9;16;17;18;33;25 0.90
11 1;3;5;6;8;12;16;17;18;20;35 0.90 1;3;5;8;9;16;17;18;25;33;34 0.91
MCI
to
AD
4 10;19;24;31 0.86 10;16;19;35 0.83 0.002
5 10;19;24;31;35 0.86 10;16;19;27;35 0.80
6 1;10;15;19;24;31 0.87 10;16;19;27;28;35 0.80
7 1;10;15;19;24;31;35 0.87 10;16;19;24;27;28;35 0.79
8 1;10;15;19;24;31;32;35 0.87 10;16;18;19;24;27;28;35 0.77
No significant difference was observed for use of GA and stepwise algorithm for prediction of progression from HC to MCI/AD, while GA was superior in
predicting progression from MCI to AD.
Table 8 P values of each variable in the different models.
Conversion from HC to MCI/AD Conversion from MCI to AD
Variables Pvalues_m1G Pvalues_m1S Pvalues_m2G Pvalues
_m2S
Variables Pvalues
_m3G
Pvalues
_m3S
Pvalues
_m4G
Pvalues
_m4S
V1 0.07 0.002 V1 0.170
V3 <0.001 <0.001 <0.001 <0.001 V10 0.011 0.019 0.056 0.011
V5 0.003 <0.001 0.014 <0.001 V15 0.048
V7 0.004 V16 0.046 0.117
V8 0.01 0.251 0.012 V18 0.245
V9 0.021 V19 0.009 0.006 0.008 0.026
V13 0.139 V24 0.043 0.034 0.124
V16 0.109 0.087 V27 0.284 0.233
V17 0.004 0.020 V28 0.092
V18 0.007 0.003 0.001 0.004 V31 0.142 0.154
V25 0.828 V32 0.549
V33 0.063 V35 0.104 0.014 0.181 0.033
The results provide statistical support for our finding that variables 3, 5 and 18 dominate prediction of progression of HC to MCI/AD. The prediction of
progression from MCI to AD consistently showed the importance of variable 19, and also of variables 10 and 35. These results indicate that for conversion of MCI
to AD, the combinations of variables are more important than the contribution of individual variables.
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solutions, as the spread of AUC values was about 0.05.
These results are consistent with the general theory of
GAs. The comparison with a stepwise algorithm available
within R package showed that the GA selected variable
sets that performed better for identifying solutions for
prediction of progression from MCI to AD or for predic-
tion of progression from a healthy status to MCI to AD
when compared to the stepwise selection. This result
emphasizes that the contribution of combined variable
sets are more important than the contributions of indivi-
dual variables for the model accuracy.
Multiple sets of neuropsychological variables were
identified by GA to best predict disease progression. For
predicting progression from being classified as healthy to
MCI or AD, the measures more frequently selected by
GA were those reflecting memory recall (v3, LMII),
memory acquisition (v5, Total Learning) and a difficult
version of semantic fluency (v18, Category Switching
Table 9 Mean values of each variable for the different clinical groups.
Variable HC MCI AD HC convert to MCI/AD MCI convert to AD
Non_
Converters
Converters Pvalue
(t,chisq)
Non_
converters
Converters Pvalue
v1 28.84 26.20 19.10 28.96 28.23 <0.001 27.37 25.79 0.002
v2 12.90 6.51 3.24 13.24 9.84 <0.001 7.53 5.91 0.034
v3 11.38 3.79 1.02 11.80 7.10 <0.001 5.03 3.04 0.012
v4 0.92 0.31 0.09 0.07 0.27 <0.001 0.60 0.70 0.498
v5 60.55 38.30 26.56 61.35 51.23 <0.001 41.07 35.40 0.001
v6 0.87 -1.37 -2.21 0.95 -0.03 <0.001 -1.18 -1.81 0.001
v7 0.79 -1.62 -2.53 0.89 -0.05 <0.001 -1.38 -2.02 0.002
v8 0.09 -1.16 -1.90 0.12 0.21 0.269 -0.98 -1.22 0.247
v9 -0.21 1.16 2.14 -0.26 0.58 <0.001 0.72 1.65 0.001
v10 0.46 -1.21 -2.06 0.52 -0.10 0.000 -0.70 -1.52 <0.001
v11 -0.54 -1.49 -3.23 -0.49 -0.84 0.052 -1.42 -1.61 0.364
v12 -1.01 -0.78 -0.49 -1.00 -1.00 0.481 -0.76 -0.76 0.488
v13 0.48 -0.82 -1.92 0.50 0.06 0.019 -0.52 -1.13 0.015
v14 0.53 -1.02 -2.15 0.56 0.06 0.016 -0.58 -1.39 0.010
v15 0.31 -1.15 -2.91 0.33 0.34 0.490 -0.36 -1.88 <0.001
v16 12.04 10.04 7.32 12.17 11.06 0.066 9.23 9.57 0.338
v17 12.38 9.03 5.31 12.50 11.87 0.120 9.23 8.83 0.305
v18 12.13 8.25 4.46 12.33 9.71 0.000 8.87 7.57 0.054
v19 12.15 8.60 4.89 12.34 9.87 0.001 9.33 7.59 0.015
v20 0.74 0.18 -1.12 0.78 0.72 0.329 0.44 0.03 0.047
v21 0.72 0.27 -0.82 0.76 0.66 0.260 0.50 0.27 0.206
v22 12.00 11.11 9.10 12.11 12.06 0.465 10.73 11.09 0.285
V23 11.68 9.85 6.53 11.76 10.65 0.019 10.13 9.33 0.131
v24 108.33 105.92 100.84 108.46 107.32 0.227 103.47 107.53 0.072
v25 111.62 108.91 104.22 111.82 110.32 0.132 106.60 110.32 0.072
v26 -0.05 0.48 2.10 -0.03 0.08 0.280 0.63 0.38 0.237
v27 0.02 0.08 0.28 0.03 0.06 0.277 0.26 0.04 0.145
v28 0.06 0.94 4.57 0.02 0.64 0.035 0.90 1.09 0.362
v29 0.08 0.17 0.64 0.07 0.23 0.147 0.19 0.29 0.254
v30 -0.34 0.35 1.83 -0.36 0.13 0.004 0.31 0.39 0.424
v31 0.73 1.55 3.08 0.67 1.06 0.105 1.00 1.76 0.074
v32 -0.32 0.05 0.57 -0.34 -0.02 0.046 -0.10 0.02 0.299
V33 9.75 9.31 7.22 9.79 9.90 0.083 9.60 9.33 0.117
V34 43.12 40.48 36.32 43.31 41.84 0.111 38.40 41.79 0.076
v35 0.04 1.21 5.74 0.03 0.15 0.025 0.73 1.37 <0.001
v36 2.62 3.71 4.06 2.56 3.07 0.116 3.90 3.24 0.148
v37 4.33 4.94 4.98 4.28 4.20 0.428 4.97 4.52 0.238
Columns HC, MCI and AD are the mean values of each variable (cognitive test). The other columns are the means values for the groups of converters and non-converters
from HC or from MCI with the t-test (chi-square test for variable 4, a dichotomous variable with values Pass and Fail) for the comparison between the 2 groups.
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Total). When considered as combinations, the measures
selected by the GA as a set to predict progression from
healthy to MCI or AD included measure of general cog-
nition (v1, MMSE), memory recall (v3, LMII), memory
acquisition (v5, Total Learning) and semantic fluency
(v18, Category Switching Total). For prediction of pro-
gression from MCI to AD, the GA selected a different set
of measures. The measures variables recognition memory
(v10, CVLT-II total Recognition d’), visual memory (v15,
Rey Complex Figure recognition), semantic fluency (v19,
Category Switching (switches)), executive function (v31,
Stroop Colour errs) and clinical dementia rating (v35,
CDR Sum of Boxes) were selected most frequently.
When considered in terms of a set of measures, one of
the best sets selected by the GA to predict progression
from MCI to AD consisted of measures of general cogni-
tion (v1, MMSE), recognition memory (v10, CVLT-II
Total Recognition d’), visual memory (v15, Rey Complex
Figure recognition), semantic fluency (v19, D-KEFS Cate-
gory Switching (switches)), IQ (v24, WAIS-III UK Pred
Full Score IQ) and executive function (v31, Stroop Col-
ours errs). Some other small variable sets selected by GA
were effective for prediction of progression to AD from
MCI. Importantly, larger sets of variables were not
selected by the GA as being predictive of prediction for
AD from MCI. As expected the GA showed that with
increases in the number of neuropsychological measures
the sets identified by the GA included increased error,
weakening their predictive utility for predicting progres-
sion to MCI or AD.
This study applied GA for prediction of AD progres-
sion by combining the results of a large set of neuropsy-
chological measures from the AIBL study that they had
been selected for their sensitivity to cognitive impair-
ment in both MCI and AD. In silico simulations with
the limited data showed the potential of GA application
in the neural science area. We have clearly demon-
strated that the combination of the variables is superior
in performance than the use of single significant vari-
ables for prediction of progression of disease. Integra-
tion of the neuropsychologists’ interpretation and
recommendation for the specific features (tests) is the
next step for extension of this study. The developed
algorithm will also be tested and adjusted with more
data collected to improve the prediction models. One of
the advantages of GA is that the fitness function can be
designed to target specific research questions directly.
The GA algorithm developed from this study was imple-
mented as a general solution that can be extended to
other prediction models.
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